Hara Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Hara Capital's BMY Position: Q1 2026 in Review
Hara Capital held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 1,910 shares worth $116K. The position accounts for 0.06% of the portfolio, ranked #144.
Hara Capital first reported a position in BMY in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.17M in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Hara Capital held 1,910 shares of Bristol-Myers Squibb worth $116K as of Q1 2026.
- Hara Capital left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.06% of Hara Capital's portfolio in Q1 2026, its #144 holding.
- Hara Capital first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 10 quarters since.
- Hara Capital's Bristol-Myers Squibb position peaked at $1.17M in Q4 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Hara Capital's 13F filing for Q1 2026, filed 14 May 2026.